Serum metabolome is associated with the nasopharyngeal microbiota and disease severity among infants with bronchiolitis

Journal of Infectious Diseases

Volumn 219, Issue 12, 2019, Pages 2005-2014

  Stewart, Christopher J ^a,e   Mansbach, Jonathan M ^b   Ajami, Nadim J ^a   Petrosino, Joseph F ^a   Zhu, Zhaozhong ^d   Liang, Liming ^d   Camargo, Carlos A ^c,d   Hasegawa, Kohei ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Bronchiolitis; Metabolomics; Microbiota; Serum; Severity

Indexed keywords

GLUCURONIC ACID; PHOSPHATIDYLCHOLINE; PLASMALOGEN; BIOLOGICAL MARKER;

ARTICLE; BLOOD SAMPLING; BRONCHIOLITIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HAEMOPHILUS; HIGH RISK PATIENT; HOSPITALIZED INFANT; HUMAN; IMMUNE RESPONSE; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METABOLIC FINGERPRINTING; METABOLITE; METABOLOMICS; MICROFLORA; MORAXELLA; NASOPHARYNX; NONHUMAN; PATHOLOGY; POPULATION ABUNDANCE; POSITIVE END EXPIRATORY PRESSURE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINOVIRUS INFECTION; RISK FACTOR; STREPTOCOCCUS; BLOOD; CLINICAL TRIAL; METABOLISM; METABOLOME; MICROBIOLOGY; MULTICENTER STUDY; PHYSIOLOGY;

BIOMARKERS; BRONCHIOLITIS; FEMALE; HUMANS; INFANT; MALE; METABOLOME; METABOLOMICS; NASOPHARYNX; POSITIVE-PRESSURE RESPIRATION; PROSPECTIVE STUDIES;

EID: 85066925116     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiz021     Document Type: Article

References (40)

1. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375:1545-55.
2. Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA Jr. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics 2013; 132:28-36.
3. Hasegawa K, Dumas O, Hartert T V, Camargo CA Jr. Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches. Expert Rev Respir Med 2016; 10:891-9.
4. Stewart CJ, Mansbach JM, Wong MC, et al. Associations of nasopharyngeal metabolome and microbiome with severity among infants with bronchiolitis. A multiomic analysis. Am J Respir Crit Care Med 2017; 196:882-91.
5. Rosas-Salazar C, Shilts MH, Tovchigrechko A, et al. Differences in the nasopharyngeal microbiome during acute respiratory tract infection with human rhinovirus and respiratory syncytial virus in infancy. J Infect Dis 2016; 214:1924-8.
6. Teo SM, Mok D, Pham K, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 2015; 17:704-15.
7. Mansbach JM, Hasegawa K, Henke DM, et al. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol 2016; 137:1909-1913.e4.
8. de Steenhuijsen Piters WA, Heinonen S, Hasrat R, et al. Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am J Respir Crit Care Med 2016; 194:1104-15.
9. Kelly RS, Dahlin A, McGeachie MJ, et al. Asthma metab-olomics and the potential for integrative omics in research and the clinic. Chest 2017; 151:262-77.
10. EMNet. Emergency Medicine Network. http://www.emnet-usa.org/. Accessed 15 January 2018.
11. Hasegawa K, Mansbach JM, Ajami NJ, et al.; the MARC-35 Investigators. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J 2016; 48:1329-39.
12. Ralston SL, Lieberthal AS, Meissner HC, et al.; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134:e1474-502.
13. Hasegawa K, Jartti T, Mansbach JM, et al. Respiratory syn-cytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis 2015; 211:1550-9.
14. Jartti T, Hasegawa K, Mansbach JM, Piedra PA, Camargo CA Jr. Rhinovirus-induced bronchiolitis: lack of association between virus genomic load and short-term outcomes. J Allergy Clin Immunol 2015; 136:509-12.e11.
15. Bijlsma S, Bobeldijk I, Verheij ER, et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 2006; 78:567-74.
16. Xia J, Sinelnikov I V, Han B, Wishart DS. MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Res 2015; 43:W251-7.
17. Team RC. R: a language and environment for statistical computing. 2014. http://www.r-project.org/. Accessed 15 January 2018.
18. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57:289-300.
19. Lê Cao KA, González I, Déjean S. integrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics 2009; 25:2855-6.
20. Nguyen DT, Louwen R, Elberse K, et al. Streptococcus pneumoniae enhances human respiratory syncytial virus infection in vitro and in vivo. PLoS One 2015; 10:e0127098.
21. Stewart CJ, Hasegawa K, Wong MC, et al. Respiratory syn-cytial virus and rhinovirus bronchiolitis are associated with distinct metabolic pathways. J Infect Dis 2018; 217:1160-9.
22. Hasegawa K, Mansbach JM, Ajami NJ, et al. The relationship between nasopharyngeal CCL5 and microbiota on disease severity among infants with bronchiolitis. Allergy 2017; 72:1796-800.
23. Hasegawa K, Linnemann RW, Mansbach JM, et al. The fecal microbiota profile and bronchiolitis in infants. Pediatrics 2016; 138:e20160218.
24. Hasegawa K, Stewart CJ, Mansbach JM, et al. Sphingolipid metabolism potential in fecal microbiome and bronchiolitis in infants: a case-control study. BMC Res Notes 2017; 10:325.
25. Vernocchi P, Del Chierico F, Putignani L. Gut micro-biota profiling: metabolomics based approach to unravel compounds affecting human health. Front Microbiol 2016; 7:1144.
26. Wikoff WR, Anfora AT, Liu J, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009; 106:3698-703.
27. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-14.
28. Samuelson DR, Welsh DA, Shellito JE. Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol 2015; 6:1085.
29. Sze MA, Tsuruta M, Yang S W, et al. Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PLoS One 2014; 9:e111228.
30. Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20:159-66.
31. Shore SA, Cho Y. Obesity and asthma: microbiome-metabolome interactions. Am J Respir Cell Mol Biol 2016; 54:609-17.
32. Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 2012; 1822:1442-52.
33. Farooqui AA, Horrocks LA. Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 2001; 7:232-45.
34. Zoeller RA, Grazia TJ, LaCamera P, Park J, Gaposchkin D P, Farber HW. Increasing plasmalogen levels protects human endothelial cells during hypoxia. Am J Physiol Heart Circ Physiol 2002; 283:H671-9.
35. Rüdiger M, von Baehr A, Haupt R, Wauer RR, Rüstow B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit Care Med 2000; 28:1572-7.
36. Rüdiger M, Tölle A, Meier W, Rüstow B. Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. Am J Physiol Lung Cell Mol Physiol 2005; 288:L379-83.
37. Wang-Sattler R, Yu Y, Mittelstrass K, et al. Metabolic profiling reveals distinct variations linked to nicotine consumption in humans-first results from the KORA study. PLoS One 2008; 3:e3863.
38. Moreno-Solís G, Dela Torre-Aguilar MJ, Torres-Borrego J, et al. Oxidative stress and inflamatory plasma biomarkers in respiratory syncytial virus bronchiolitis. Clin Respir J 2017; 11:839-46.
39. Biswas SK, Rahman I. Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Mol Aspects Med 2009; 30:60-76.
40. Mansbach JM, Hasegawa K, Ajami NJ, et al. Serum LL-37 levels associated with severity of bronchiolitis and viral etiology. Clin Infect Dis 2017; 65:967-75.